| Edição |
Seção |
Título |
Arquivo |
| Nº 16 (2012) |
Articles |
Pompovaya insulinoterapiya: novye tekhnologii v sovremennoy klinicheskoy praktike |
|
| Nº 16 (2012) |
Articles |
Nastoyashchee i budushchee farmakoterapii akromegalii |
|
| Nº 16 (2012) |
Articles |
Rannee naznachenie insulina glargin patsientam s sakharnym diabetom 2 tipa, prediabetom i vysokim serdechno-sosudistym riskom: rezul'taty issledovaniya ORIGIN |
|
| Nº 16 (2012) |
Articles |
Rol' taurina i ego defitsita v organizme cheloveka i zhivotnykh |
|
| Nº 16 (2012) |
Articles |
Naznachenie sakharosnizhayushchego preparata patsientu - chto eshche neobkhodimo, krome retsepta? |
|
| Nº 16 (2012) |
Articles |
Opyt ispol'zovaniya novoy formy gliklazida MV 60 mg (Diabeton MV 60 mg) v terapii bol'nykh sakharnym diabetom 2 tipa |
|
| Nº 5 (2013) |
Articles |
SOVETNIK BOLYuSA": EFFEKTIVNOE I BEZOPASNOE UPRAVLENIE POSTPRANDIAL'NOY GLIKEMIEY U PATsIENTOV NA POMPOVOY INSULINOTERAPII |
|
| Nº 5 (2013) |
Articles |
INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY |
|
| Nº 5 (2013) |
Articles |
FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA |
|
| Nº 5 (2013) |
Articles |
AKROMEGALIYa: VAZhNOST' OTsENKI SISTEMNYKh PROYaVLENIY ZABOLEVANIYa I IKh TERAPII, ROL' ANALOGOV SOMATOSTATINA |
|
| Nº 5 (2013) |
Articles |
PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa |
|
| Nº 5 (2013) |
Articles |
BIOSIMILYaRY: PROBLEMY ZAMEShchENIYa I SOVREMENNYE TREBOVANIYa K VOSPROIZVEDENNYM PREPARATAM INSULINA |
|
| Nº 16 (2013) |
Articles |
Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa |
|
| Nº 16 (2013) |
Articles |
Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki |
|
| Nº 16 (2013) |
Articles |
Opyt vedeniya Moskovskogo registra bol'nykh akromegaliey: vozmozhnosti resheniya razlichnykh terapevticheskikh zadach |
|
| Nº 16 (2013) |
Articles |
Dolgosrochnaya bezopasnost' i effektivnost' insulina aspart u patsientov s sakharnym diabetom 1 tipa |
|
| Nº 5 (2014) |
Articles |
PROTIVOOPUKhOLEVYY EFFEKT ANALOGOV SOMATOSTATINA PRI SOMATOTROPINOMAKh: OBZOR POSLEDNIKh ISSLEDOVANIY |
|
| Nº 5 (2014) |
Articles |
UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa |
|
| Nº 16 (2014) |
Articles |
Optimizatsiya lecheniya patsientov s akromegaliey: uvelichenie intervala mezhdu in\"ektsiyami pri ispol'zovanii lanreotida |
|
| Nº 16 (2014) |
Articles |
Novye podkhody k terapii bolezni Itsenko-Kushinga |
|
| Nº 5 (2015) |
Articles |
Klinicheskaya inertsiya v terapii sakharnogo diabeta 2 tipa |
|
| Nº 5 (2015) |
Articles |
Ispol'zovanie kliniko-laboratornykh prediktorov v prognozirovanii antisekretornogo i antiproliferativnogo deystviya analogov somatostatina pri lechenii akromegalii: obzor poslednikh issledovaniy |
|
| Nº 5 (2015) |
Articles |
Effektivnost' trekhkomponentnoy terapii s ispol'zovaniem liraglutida (Viktoza) -pervogo analoga glyukagonopodobnogo peptida-1 dlitel'nogo deystviya - u patsientov s sakharnym diabetom 2 tipa i vistseral'nym ozhireniem |
|
| Nº 17 (2015) |
Articles |
Novye podkhody k diagnostike i lecheniyu neyroendokrinnykh opukholey |
|
| Nº 17 (2015) |
Articles |
Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa |
|
| Nº 5 (2016) |
Articles |
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS |
|
| Nº 16 (2016) |
Articles |
Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety |
|
| Nº 16 (2016) |
Articles |
Clinical characteristics and practical aspects of the use of new basal insulin glargine 300 U/ml Toujeo SoloStar® |
|
| Nº 16 (2016) |
Articles |
Modern approaches to the treatment of patients with type 2 diabetes mellitus |
|
| Nº 16 (2016) |
Articles |
Moscow registry of patients with acromegaly: long-term results of observations |
|
| Nº 16 (2016) |
Articles |
Features of use of dapagliflozin in thetreatment of patients with type 2 diabetes mellitus |
|
| Nº 5 (2017) |
Articles |
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE |
|
| Nº 5 (2017) |
Articles |
STRATEGY OF ACTIVE SEARCH FOR PATIENTS WITH ACROMEGALY: CASE REPORT |
|
| Nº 16 (2017) |
Articles |
Increasing the dose of somatostatin analogues of in patients with active form of acromegaly: literature review and prospects for application |
|
| Nº 16 (2017) |
Articles |
Diabetic distal polyneuropathy: the principles of diagnostics and therapy |
|
| Nº 16 (2017) |
Articles |
The use of insulin glargine 300 lU/ml (Toujeo SoloStar®) in real clinical practice |
|
| Nº 16 (2017) |
Articles |
Effect of SGLT-2 inhibitors on cardiovascular outcomes: review of results of CVD-REAL trial |
|
| Nº 4 (2018) |
Articles |
ACROMEGALY AND COMORBIDITY: DIAGNOSIS AND TREATMENT |
|
| Nº 4 (2018) |
Articles |
MOSCOW EXPERIENCE OF APPLICATION OF A NEW LONG-ACTING INSULIN ANALOGUE |
|
| Nº 11 (2018) |
Articles |
Potentials for the management of cardiovascular risk in diabetic patients on insulin therapy |
|
| Nº 11 (2018) |
Articles |
Initiation of insulin therapy in patients with type 2 diabetes mellitus according to the Federal Diabetes Register in Moscow |
|
| Nº 11 (2018) |
Articles |
Type 1 diabetes mellitus in Moscow -2018 (according to the Moscow segment of the Federal Diabetes Register) |
|
| Volume 26, Nº 4 (2019) |
Articles |
Experience of the use of insulin degludec in the treatment of patients with type 1 diabetes mellitus (according to the data of the Moscow segment of the Federal Diabetes Register) |
|
| Volume 26, Nº 14 (2019) |
Articles |
Start of therapy of type 2 diabetes mellitus with a fixed combination. Metformin with vildagliptin or glibenclamide, is there any difference? |
|
| Volume 26, Nº 14 (2019) |
Articles |
Experience in the integrated use of organizational approaches and clinical tools to achieve glycemic control goals |
|
| Volume 27, Nº 4 (2020) |
Articles |
Predictors of the effectiveness of drug therapy of acromegaly (according to the Moscow register) |
|
| Volume 27, Nº 12 (2020) |
Articles |
Modern approaches to using the FreeStyle Libre Flash glucose monitoring system |
|
| Volume 27, Nº 12 (2020) |
Articles |
Experience of using pegvisomantin the combined treatment of acromegaly |
|
| Volume 28, Nº 4 (2021) |
Articles |
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice |
|
| Volume 28, Nº 4 (2021) |
Articles |
Rational pharmacotherapy of acromegaly: focus on treatment adherence |
|
| Volume 28, Nº 12 (2021) |
Articles |
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus |
|
| Volume 29, Nº 4 (2022) |
Articles |
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin |
|
| Volume 29, Nº 4 (2022) |
Articles |
Optimization of drug treatment of acromegaly (clinical and morphological comparison) |
|
| Volume 29, Nº 4 (2022) |
Articles |
The efficacy of pegvisomant in patients with acromegaly resistant to 1st generation somatostatin analogues |
|
| Volume 29, Nº 4 (2022) |
Articles |
The use of the last generation insulin analogues for the control of diabetes mellitus in real clinical practice |
|
| Volume 29, Nº 7 (2022) |
Articles |
Evaluation of the effectiveness of combination therapy with somatostatin analogues and D2-dopamine receptor agonists in the treatment of persistent or recurrent course of Cushing’s disease |
|
| Volume 29, Nº 11/12 (2022) |
Articles |
Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study |
|
| Volume 29, Nº 11/12 (2022) |
Articles |
Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus |
|
